Skip to content
Open access

Composite Complete-Blood-Count-Derived Inflammatory Indices for Discriminating Established Major Organ Involvement in Behçet’s Disease: A Cross-Sectional Nomogram Model

Oct 2026 · Journal of Clinical Medicine · Vol 15, pp. 8067 · 0 citations · 25 references
Medicine

TL;DR

Conventional acute-phase reactants fail to reflect established MOI in BD patients receiving maintenance therapies outside acute flares, and composite CBC-derived indices—SIRI, SII and AISI—exhibit strong discriminative accuracy.

Abstract

Introduction: Differentiating major organ involvement (MOI) from isolated mucocutaneous manifestations in Behçet’s disease (BD) remains a substantial clinical challenge, particularly in stable outpatients outside acute flares. This study aimed to evaluate the cross-sectional discriminatory utility of complete blood count (CBC)-derived composite inflammatory indices—specifically the Systemic Inflammatory Response Index (SIRI), Systemic Immuno-Inflammatory Index (SII), and Aggregate Index of Systemic Inflammation (AISI)—and to construct an internally validated diagnostic nomogram. Methods: A total of 178 BD patients (88 with established MOI and 90 with isolated mucocutaneous involvement) classified according to the 2014 International Criteria for Behçet’s Disease (ICBD) were included in this cross-sectional study. Concurrently measured hematological parameters, acute-phase reactants (Erythrocyte Sedimentation Rate [ESR] and C-Reactive Protein [CRP]), and ongoing therapies were analyzed. Discriminative performance was evaluated using receiver operating characteristic (ROC) curves. Independent indicators of MOI were identified via multivariable Firth’s penalized logistic regression, and a nomogram was generated with 1000-sample bootstrap internal validation. Results: In the MOI group, SIRI, SII, and AISI levels were statistically significantly higher than in the mucocutaneous group (p < 0.001); in contrast, no statistically significant difference was observed in ESR and CRP levels (p > 0.05). SIRI provided the highest numerical point estimate for AUC (0.919, 95% CI: 0.880–0.956); however, formal matched ROC comparisons showed that SIRI’s discriminatory performance was statistically comparable to that of AISI (AUC: 0.916; p = 0.800) and SII (AUC: 0.889; p = 0.211). In a multivariable analysis adjusted for age, sex, and duration of illness, SIRI remained strongly and independently associated with MOI (adjusted OR: 90.19, 95% CI: 22.20–366.44, p < 0.001). The SIRI-based diagnostic nomogram demonstrated robust calibration and discriminatory power (optimism-adjusted AUC = 0.912, Brier score = 0.115). Conclusions: Conventional acute-phase reactants fail to reflect established MOI in BD patients receiving maintenance therapies outside acute flares. In contrast, composite CBC-derived indices—SIRI, SII and AISI—exhibit strong discriminative accuracy. The internally validated nomogram provides an accessible clinical stratification tool. However, the present cross-sectional data do not establish prediction of future MOI, prognosis, or subclinical vasculitis.

Read PDF

Similar papers

Open access Sep 2026

Exploratory evaluation of the complete blood count-derived hematologic indices for diagnostic discrimination of rheumatoid arthritis and their relationship with disease activity: a cross-sectional study

Background. Hematologic indices derived from the complete blood count (CBC) have attracted interest as potential inflammatory biomarkers in rheumatoid arthritis (RA). These indices include red cell distribution width (RDW), mean platelet volume (MPV), and platelet distribution width (PDW). The aim of this study was to...

R. Gamal, Ebrahim El Boghdady, H. A. Tawab et al. · 0 citations
Open access Oct 2026

Nutritional-inflammatory and laboratory-derived fibrosis indices in FMF-related AA amyloidosis: associations with advanced kidney disease and mortality

Aims: Amyloid A (AA) amyloidosis is among the most serious systemic consequences of familial Mediterranean fever (FMF), particularly because of its renal burden. We investigated whether the fibrosis-4 index (FIB-4), the Aspartate Aminotransferase to-Platelet Ratio Index (APRI), HALP, and Prognostic Nutritional Index (P...

EC Bölek, Burak Karakaya, R. Kardaş et al. · 0 citations
Open access Oct 2026

Predictive value of systemic immune-inflammatory indices for severe acute cholangitis and in-hospital mortality

Acute cholangitis (AC) is a potentially life-threatening biliary infection requiring early identification of patients at risk for severe disease and in-hospital mortality. While several systemic immune-inflammatory indices derived from routine laboratory tests have been proposed as prognostic biomarkers, their he...

Metin Oner, I. Altundag, Alperen Şahin et al. · 0 citations
Open access Sep 2026

Complete Blood Count-Derived Inflammatory Indices and Systemic Inflammatory Burden in Children with Rheumatic Manifestations Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection or Exposure: A Retrospective Study

Introduction. Rheumatic, vascular, musculoskeletal, and systemic inflammatory manifestations have been de­scribed in children after SARS-CoV-2 infection. Indices derived from the complete blood count may reflect sys­temic inflammatory burden without additional blood sampling or laboratory cost. The aim of the study. T...

E. Nakhutsrishvili, T. Kutubidze, R. Rajesh · 0 citations
Open access Sep 2026

Aggregate Index of Systemic Inflammation in Behçet’s Disease: Association with Disease Activity

Objective: The aggregate index of systemic inflammation (AISI) is a recently introduced composite inflammatory marker derived from neutrophil, monocyte, lymphocyte, and platelet counts. This study aimed to evaluate AISI values in patients with Behçet’s disease (BD), compare them with healthy controls, and investigate t...

Zeynep Kaya, S. Ösken · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.